Atlas Prime

PhotronicsPLAB

Photronics, Inc., including its affiliated entities, operates as a global supplier focused on the production and distribution of photomask goods and associated services. The company's reach extends across the United States, Taiwan, Korea, Europe, and China, serving international markets. These photomasks are vital for the manufacturing of integrated circuits (ICs) and flat panel displays (FPDs), enabling the precise transfer of circuit patterns onto semiconductor wafers, FPD substrates, and various other electrical and optical components. Photronics markets its offerings to a broad customer base, encompassing semiconductor and FPD manufacturers, designers, foundries, and other producers of high-performance electronics, facilitated by its sales personnel and customer service representatives. Founded in 1969, the company was originally known as Photronic Labs, Inc., changing to Photronics, Inc. in 1990. Its principal office is situated in Brookfield, Connecticut.

Last
—
1D
—
1W
—
1M
—
Next earnings: December 9, 2026

Research memo

PLAB still screens as a photomask recovery name, but the tape is no longer asking for a perfect cycle. With market capitalization of $1.79 billion, enterprise value of $1.12 billion, and EV/revenue at 1.3x on $849.3 million of revenue, the market is paying for utilization and mix rather than a growth rerating. The setup now turns on whether advanced-node demand and factory loading stay firm enough to pull margins higher over the next few quarters.

Hard data

  • Market cap: $1.79 billion
  • Enterprise value: $1.12 billion
  • Revenue: $849.3 million
  • Gross margin: 33.2%
  • Next revenue growth: 7.3%
  • EV/revenue: 1.3x
  • Price snapshot: unavailable until /api/cron/daily runs
  • Market context: Fear & Greed Index 74 (Greed)

Thesis

Photomasks are the chokepoint: Photronics makes the patterned plates chipmakers use to print circuits onto wafers, so earnings are driven by utilization, mix, and pricing in advanced logic, memory, and advanced packaging. The stock already discounts a recovery at 1.3x EV/revenue; the part consensus can still miss is how fast small improvements in loading and high-end mix fall through to margins when fabs stop running lean. The strongest pushback is that this is still a mature semiconductor consumable with no durable structural growth, and if wafer starts stay uneven or inventory digestion drags on, the recovery can fade before it broadens. That is fair, but the base case still holds if high-end mask demand stays tight first and then spreads, because even modest improvements in utilization can move earnings faster than the market usually models over the next few quarters.

Bear case

The bear case is that PLAB remains a cyclical supplier with no lasting growth engine. If semiconductor capex stays choppy, customers keep working down inventory, or advanced-node demand remains concentrated in a few pockets, photomask pricing and utilization can stay stuck near trough levels. In that version, the stock stays cheap because reported revenue can stabilize without any real earnings re-rating.

Invalidation

The setup breaks if utilization and pricing fail to improve over the next two to three quarters, or if gross margin rolls back toward the low-30% area and stays there despite a broader semiconductor recovery.

Trade framing

At 1.3x EV/revenue with greed in the tape, this is more a cycle-expression name than a deep-value story. If margins keep grinding up, the market can still pay for leverage, but the cleanest risk/reward is to own it only while the utilization trend is improving; if the next couple of quarters do not confirm that, the multiple can compress quickly.